{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T01:05:06Z","timestamp":1793754306713,"version":"4.6.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T00:00:00Z","timestamp":1699920000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T00:00:00Z","timestamp":1699920000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Johann Wolfgang Goethe-Universit\u00e4t, Frankfurt am Main"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Neuroradiol"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1007\/s00062-023-01358-z","type":"journal-article","created":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T08:02:49Z","timestamp":1699948969000},"page":"503-506","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Toxic Leukoencephalopathy due to Suspected Levamisole-adulterated Cocaine"],"prefix":"10.1007","volume":"34","author":[{"ORCID":"https:\/\/orcid.org\/0009-0007-4976-6890","authenticated-orcid":false,"given":"Rafael","family":"Willems","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8247-1938","authenticated-orcid":false,"given":"Se-Jong","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friederike","family":"Vollmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8392-9004","authenticated-orcid":false,"given":"Elke","family":"Hattingen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6437-6793","authenticated-orcid":false,"given":"Stefan","family":"Weidauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,14]]},"reference":[{"key":"1358_CR1","doi-asserted-by":"publisher","first-page":"208","DOI":"10.1186\/s12883-015-0467-1","volume":"15","author":"R Vosoughi","year":"2015","unstructured":"Vosoughi\u00a0R, Schmidt\u00a0BJ. Multifocal leukoencephalopathy in cocaine users: a\u00a0report of two cases and review of the literature. BMC Neurol. 2015;15:208.","journal-title":"BMC Neurol"},{"issue":"4","key":"1358_CR2","doi-asserted-by":"publisher","first-page":"231","DOI":"10.3109\/15563650.2012.665455","volume":"50","author":"A Larocque","year":"2012","unstructured":"Larocque\u00a0A, Hoffman\u00a0RS. Levamisole in cocaine: unexpected news from an old acquaintance. Clin Toxicol (phila). 2012;50(4):231\u201341.","journal-title":"Clin Toxicol (phila)"},{"issue":"4","key":"1358_CR3","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1552-6569.2008.00344.x","volume":"19","author":"N Xu","year":"2009","unstructured":"Xu\u00a0N, Zhou\u00a0W, Li\u00a0S, Zhou\u00a0G, Zhang\u00a0N, Liang\u00a0J. Clinical and MRI characteristics of levamisole-induced leukoencephalopathy in 16\u00a0patients. J\u00a0Neuroimaging. 2009;19(4):326\u201331.","journal-title":"J Neuroimaging"},{"issue":"4","key":"1358_CR4","first-page":"262","volume":"20","author":"YC Cheng","year":"2011","unstructured":"Cheng\u00a0YC, Po\u00a0HL. Leukoencephalopathy after levamisole for the treatment of verrucae. Acta Neurol Taiwan. 2011;20(4):262\u20136.","journal-title":"Acta Neurol Taiwan"},{"issue":"1","key":"1358_CR5","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1006\/exnr.1997.6598","volume":"147","author":"CF Lucchinetti","year":"1997","unstructured":"Lucchinetti\u00a0CF, Kimmel\u00a0DW, Pavelko\u00a0K, Rodriguez\u00a0M. 5\u2011Fluorouracil and levamisole exacerbate demyelination in susceptible mice infected with Theiler\u2019s virus. Exp Neurol. 1997;147(1):123\u20139.","journal-title":"Exp Neurol"},{"key":"1358_CR6","doi-asserted-by":"publisher","first-page":"100058","DOI":"10.1016\/j.nerep.2022.100058","volume":"2","author":"L C\u00f4rtes","year":"2022","unstructured":"C\u00f4rtes\u00a0L, Santana\u00a0S, Fukuda\u00a0TG, Bacellar\u00a0A. Central nervous system demyelination following isolated levamisole use: Case report and systematic review. Neuroimmunol Reports. 2022;2:100058.","journal-title":"Neuroimmunol Reports"},{"issue":"3","key":"1358_CR7","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1093\/anatox\/35.3.176","volume":"35","author":"KL Lynch","year":"2011","unstructured":"Lynch\u00a0KL, Dominy\u00a0SS, Graf\u00a0J, Kral\u00a0AH. Detection of levamisole exposure in cocaine users by liquid chromatography-tandem mass spectrometry. J\u00a0Anal Toxicol. 2011;35(3):176\u20138.","journal-title":"J Anal Toxicol"},{"key":"1358_CR8","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1016\/j.jneuroim.2017.01.018","volume":"305","author":"JR Vitt","year":"2017","unstructured":"Vitt\u00a0JR, Brown\u00a0EG, Chow\u00a0DS, Josephson\u00a0SA. Confirmed case of levamisole-associated multifocal inflammatory leukoencephalopathy in a\u00a0cocaine user. J\u00a0Neuroimmunol. 2017;305:128\u201330.","journal-title":"J Neuroimmunol"},{"issue":"1","key":"1358_CR9","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1186\/s42466-022-00202-y","volume":"4","author":"N Tollens","year":"2022","unstructured":"Tollens\u00a0N, Post\u00a0P, Dos\u00a0MSM, Niggemann\u00a0P, Warken\u00a0M, Wolf\u00a0J. Multifocal leukoencephalopathy associated with intensive use of cocaine and the adulterant levamisole in a\u00a029-year old patient. Neurol Res Pract. 2022;4(1):38.","journal-title":"Neurol Res Pract"},{"issue":"1","key":"1358_CR10","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1007\/s13181-014-0422-3","volume":"11","author":"P Hantson","year":"2015","unstructured":"Hantson\u00a0P, Di Fazio\u00a0V, Del Mar Ramirez Fernandez\u00a0M, Samyn\u00a0N, Duprez\u00a0T, van Pesch\u00a0V. Susac-like syndrome in a\u00a0chronic cocaine abuser: could levamisole play a\u00a0role? J\u00a0Med Toxicol. 2015;11(1):124\u20138.","journal-title":"J Med Toxicol"},{"key":"1358_CR11","doi-asserted-by":"publisher","first-page":"311","DOI":"10.12659\/PJR.901791","volume":"82","author":"Y Kumar","year":"2017","unstructured":"Kumar\u00a0Y, Drumsta\u00a0D, Mangla\u00a0M, Gupta\u00a0N, Hooda\u00a0K, Almast\u00a0J, et\u00a0al. Toxins in Brain! Magnetic Resonance (MR) Imaging of Toxic Leukoencephalopathy\u2014A Pictorial Essay. Pol J Radiol. 2017;82:311\u20139.","journal-title":"Pol J Radiol"},{"issue":"3","key":"1358_CR12","doi-asserted-by":"publisher","first-page":"879","DOI":"10.2214\/AJR.08.2257","volume":"193","author":"P Sharma","year":"2009","unstructured":"Sharma\u00a0P, Eesa\u00a0M, Scott\u00a0JN. Toxic and acquired metabolic encephalopathies: MRI appearance. AJR Am J Roentgenol. 2009;193(3):879\u201386.","journal-title":"AJR Am J Roentgenol"},{"issue":"6","key":"1358_CR13","doi-asserted-by":"publisher","first-page":"1672","DOI":"10.1148\/rg.2019190016","volume":"39","author":"AM de Oliveira","year":"2019","unstructured":"de Oliveira\u00a0AM, Paulino\u00a0MV, Vieira\u00a0APF, McKinney\u00a0AM, da Rocha\u00a0AJ, Dos\u00a0SGT, et\u00a0al. Imaging Patterns of Toxic and Metabolic Brain Disorders. Radiographics. 2019;39(6):1672\u201395.","journal-title":"Radiographics"},{"issue":"4","key":"1358_CR14","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1136\/jnnp.2006.088955","volume":"78","author":"D Kondziella","year":"2007","unstructured":"Kondziella\u00a0D, Danielsen\u00a0ER, Arlien-Soeborg\u00a0P. Fatal encephalopathy after an isolated overdose of cocaine. J\u00a0Neurol Neurosurg Psychiatry. 2007;78(4):437\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"7","key":"1358_CR15","doi-asserted-by":"publisher","first-page":"1014","DOI":"10.1136\/jnnp.2004.047134","volume":"76","author":"A Ryan","year":"2005","unstructured":"Ryan\u00a0A, Molloy\u00a0FM, Farrell\u00a0MA, Hutchinson\u00a0M. Fatal toxic leukoencephalopathy: clinical, radiological, and necropsy findings in two patients. J\u00a0Neurol Neurosurg Psychiatry. 2005;76(7):1014\u20136.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"1358_CR16","doi-asserted-by":"publisher","first-page":"1765","DOI":"10.1212\/WNL.53.8.1765","volume":"53","author":"AR Kriegstein","year":"1999","unstructured":"Kriegstein\u00a0AR, Shungu\u00a0DC, Millar\u00a0WS, Armitage\u00a0BA, Brust\u00a0JC, Chillrud\u00a0S, et\u00a0al. Leukoencephalopathy and raised brain lactate from heroin vapor inhalation (\u201cchasing the dragon\u201d). Neurology. 1999;53(8):1765\u201373.","journal-title":"Neurology"},{"key":"1358_CR17","doi-asserted-by":"crossref","unstructured":"Blanc PD, Chin C, Lynch KL. Multifocal inflammatory leukoencephalopathy associated with cocaine abuse: is levamisole responsible? Clin Toxicol (Phila). 2012;50(6):534\u20135; author reply 6.","DOI":"10.3109\/15563650.2012.692794"},{"key":"1358_CR18","doi-asserted-by":"publisher","first-page":"242","DOI":"10.1016\/j.forsciint.2011.06.027","volume":"212(1\u20133","author":"S Schneider","year":"2011","unstructured":"Schneider\u00a0S, Meys\u00a0F. Analysis of illicit cocaine and heroin samples seized in Luxembourg from 2005\u20132010. Forensic Sci Int. 2011;212(1\u20133:242\u20136.","journal-title":"Forensic Sci Int"},{"issue":"2","key":"1358_CR19","doi-asserted-by":"publisher","first-page":"E281","DOI":"10.1503\/jpn.200057","volume":"46","author":"F Conrad","year":"2021","unstructured":"Conrad\u00a0F, Hirsiger\u00a0S, Winklhofer\u00a0S, Baumgartner\u00a0MR, Stampfli\u00a0P, Seifritz\u00a0E, et al. Use of levamisole-adulterated cocaine is associated with increased load of white matter lesions. J\u00a0Psychiatry Neurosci. 2021;46(2):E281\u2013E91.","journal-title":"J Psychiatry Neurosci"},{"issue":"1","key":"1358_CR20","doi-asserted-by":"publisher","first-page":"71","DOI":"10.3892\/etm.2013.1077","volume":"6","author":"R Yan","year":"2013","unstructured":"Yan\u00a0R, Wu\u00a0Q, Ren\u00a0J, Cui\u00a0H, Zhai\u00a0K, Zhai\u00a0Z, et\u00a0al. Clinical features and magnetic resonance image analysis of 15\u00a0cases of demyelinating leukoencephalopathy induced by levamisole. Exp Ther Med. 2013;6(1):71\u20134.","journal-title":"Exp Ther Med"},{"issue":"4","key":"1358_CR21","doi-asserted-by":"publisher","first-page":"410","DOI":"10.1016\/j.neuro.2011.03.005","volume":"32","author":"F Bianco","year":"2011","unstructured":"Bianco\u00a0F, Iacovelli\u00a0E, Tinelli\u00a0E, Lepre\u00a0C, Pauri\u00a0F. Recurrent leukoencephalopathy in a\u00a0cocaine abuser. Neurotoxicology. 2011;32(4):410\u20132.","journal-title":"Neurotoxicology"},{"issue":"12","key":"1358_CR22","doi-asserted-by":"publisher","first-page":"4077","DOI":"10.1007\/s00216-013-6829-x","volume":"405","author":"C Hess","year":"2013","unstructured":"Hess\u00a0C, Ritke\u00a0N, Broecker\u00a0S, Madea\u00a0B, Musshoff\u00a0F. Metabolism of levamisole and kinetics of levamisole and aminorex in urine by means of LC-QTOF-HRMS and LC-QqQ-MS. Anal Bioanal Chem. 2013;405(12):4077\u201388.","journal-title":"Anal Bioanal Chem"},{"issue":"10","key":"1358_CR23","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1002\/dta.1619","volume":"6","author":"C Hess","year":"2014","unstructured":"Hess\u00a0C, Ritke\u00a0N, Sydow\u00a0K, Mehling\u00a0LM, Ruehs\u00a0H, Madea\u00a0B, et al. Determination of levamisole, aminorex, and pemoline in plasma by means of liquid chromatography-mass spectrometry and application to a\u00a0pharmacokinetic study of levamisole. Drug Test Anal. 2014;6(10):1049\u201354.","journal-title":"Drug Test Anal"},{"issue":"935","key":"1358_CR24","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1259\/bjr\/61535842","volume":"78","author":"E Bartlett","year":"2005","unstructured":"Bartlett\u00a0E, Chasing\u00a0MDJ. \u201cchasing the dragon\u201d with MRI: leukoencephalopathy in drug abuse. Br J Radiol. 2005;78(935):997\u20131004.","journal-title":"Br J Radiol"},{"issue":"7","key":"1358_CR25","first-page":"1475","volume":"24","author":"RN Sener","year":"2003","unstructured":"Sener\u00a0RN. Acute carbon monoxide poisoning: diffusion MR imaging findings. AJNR Am J Neuroradiol. 2003;24(7):1475\u20137.","journal-title":"AJNR Am J Neuroradiol"},{"key":"1358_CR26","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1007\/s00062-010-0022-9","volume":"20(1","author":"S Blasel","year":"2010","unstructured":"Blasel\u00a0S, Hattingen\u00a0E, Adelmann\u00a0M, Nichtweiss\u00a0M, Zanella\u00a0F, Weidauer\u00a0S. Toxic leukoencephalopathy after heroin abuse without heroin vapor inhalation: MR imaging and clinical features in three patients. Clin Neuroradiol. 2010;20(1:48\u201353.","journal-title":"Clin Neuroradiol"},{"key":"1358_CR27","first-page":"TD9","volume":"11(7):TD08","author":"G Sindhwani","year":"2017","unstructured":"Sindhwani\u00a0G, Arora\u00a0M, Thakker\u00a0VD, Jain\u00a0A. MRI in Chemotherapy induced Leukoencephalopathy: Report of Two Cases and Radiologist\u2019s Perspective. J\u00a0Clin Diagn Res. 2017;11(7):TD08:TD9.","journal-title":"J Clin Diagn Res"},{"issue":"1020","key":"1358_CR28","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1259\/bjr\/25273221","volume":"85","author":"CJ Stevens","year":"2012","unstructured":"Stevens\u00a0CJ, Heran\u00a0MK. The many faces of posterior reversible encephalopathy syndrome. Br J Radiol. 2012;85(1020):1566\u201375.","journal-title":"Br J Radiol"},{"issue":"2","key":"1358_CR29","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1053\/j.sult.2013.09.009","volume":"35","author":"AM Alleman","year":"2014","unstructured":"Alleman\u00a0AM. Osmotic demyelination syndrome: central pontine myelinolysis and extrapontine myelinolysis. Semin Ultrasound CT MR. 2014;35(2):153\u20139.","journal-title":"Semin Ultrasound CT MR"},{"issue":"6","key":"1358_CR30","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.crad.2012.05.021","volume":"68","author":"G Bathla","year":"2013","unstructured":"Bathla\u00a0G, Hegde\u00a0AN. MRI and CT appearances in metabolic encephalopathies due to systemic diseases in adults. Clin Radiol. 2013;68(6):545\u201354.","journal-title":"Clin Radiol"},{"issue":"9","key":"1358_CR31","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.3174\/ajnr.A1139","volume":"29","author":"A Rovira","year":"2008","unstructured":"Rovira\u00a0A, Alonso\u00a0J, Cordoba\u00a0J. MR imaging findings in hepatic encephalopathy. AJNR Am J Neuroradiol. 2008;29(9):1612\u201321.","journal-title":"AJNR Am J Neuroradiol"},{"key":"1358_CR32","doi-asserted-by":"crossref","unstructured":"Beltz EE, Mullins ME. Hyperintensity of the basal ganglia and cortex on FLAIR and diffusion-weighted imaging: self-assessment module. AJR Am J Roentgenol. 2010;195(3 Suppl):S9\u201311.","DOI":"10.2214\/AJR.10.7261"}],"container-title":["Clinical Neuroradiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00062-023-01358-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00062-023-01358-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00062-023-01358-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,27]],"date-time":"2024-05-27T16:01:57Z","timestamp":1716825717000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00062-023-01358-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,14]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["1358"],"URL":"https:\/\/doi.org\/10.1007\/s00062-023-01358-z","relation":{},"ISSN":["1869-1439","1869-1447"],"issn-type":[{"value":"1869-1439","type":"print"},{"value":"1869-1447","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,14]]},"assertion":[{"value":"1 September 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"R.\u00a0Willems, S.-J.\u00a0You, F.\u00a0Vollmer, E.\u00a0Hattingen and S.\u00a0Weidauer declare that they have no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}